top of page

Why the Advanced Radioisotope
Manufacturing Facility Matters

The infrastructure, investment and specialist expertise behind entX's ambition to advance Australia's medical isotope manufacturing capability.

WATCH THE FULL interview

Watch the extended video to learn how IsoMedica is helping secure the future of medical isotope supply and radiopharmaceutical innovation.

entX_IsoMedica-Webinar-Cover2.png

Establishing a commercial medical isotope manufacturing facility requires far more than laboratory space. It demands specialised infrastructure, significant capital investment, complex regulatory approvals and a highly skilled workforce.

​

Through its Advanced Radioisotope Manufacturing Facility (ARMF), entX is bringing these critical capabilities together to support the future production of medical isotopes in Australia.

Significant Barriers to Entry

Operating a facility of this nature requires purpose-built hot cells and shielded enclosures, advanced radiation safety systems, specialised engineering and strict regulatory compliance.

​

These requirements represent a substantial investment of both time and capital. Hot cells alone can cost millions of dollars, while obtaining regulatory approvals and developing the specialist workforce needed for safe, compliant operations can take years.

​

As a result, the combination of infrastructure, regulatory expertise and operational capability required to establish an advanced radioisotope manufacturing facility creates significant barriers to entry, particularly in Australia.

Building Australia's Medical Isotope Capability

Through the ARMF, entX has brought these essential components together, establishing the infrastructure and expertise needed to support commercial medical isotope production.

​

This capability represents an important foundation for IsoMedica and entX's broader ambitions in the growing radiopharmaceutical and targeted alpha therapy markets.

By combining specialised infrastructure, regulatory capability and an experienced team, entX is working to establish a differentiated position in Australia's medical isotope manufacturing sector.

OTher Projects

Medical Isotopes

212-Pb

Supply chain process for the manufacture of Lead-212 radiopharmaceuticals

Space & Defence

RHU

Generating heat for critical electronics and lithium batteries to survive the extreme low temperatures of the lunar night.

Space & Defence

GEN X

Maintenance-Free, long term Power for unmanned, remote and challenging Space and Defence applications.

bottom of page